NCT01670383 Repository for Sepsis and Postresuscitation Samples
| NCT ID | NCT01670383 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2006-07 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2006-07 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to find a new therapeutic strategy by investigating the serial serum samples of patients with sepsis or postresuscitation state.
Eligibility Criteria
Inclusion Criteria: * Age over 16 years old * Admitted to ICU * Diagnosed as having sepsis or as postresuscitation status * Definition of sepsis: 2 or more SIRS criteria + infection is suspected * Definition of postresuscitation status: Survived from non-traumatic cardiac arrest Exclusion Criteria: * refusal to participate * DNAR status
Contact & Investigator
Gil Joon Suh, Professor
STUDY DIRECTOR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT01670383 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01670383 currently recruiting?
Yes, NCT01670383 is actively recruiting participants. Contact the research team at kanesu@gmail.com for enrollment information.
Where is the NCT01670383 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT01670383 clinical trial?
NCT01670383 is sponsored by Seoul National University Hospital. The principal investigator is Gil Joon Suh, Professor at Seoul National University Hospital. The trial plans to enroll 500 participants.